ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
63 030,49
6,61%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aldeyra Therapeutics Inc (ALDX)

  7. Aldeyra Therapeutics Inc (ALDX) Actualités

ALDX Aldeyra Therapeutics Inc

4,16
-0,05 (-1,19%)
Après les heures de négociation
Dernière mise à jour : 01:02:29
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aldeyra Therapeutics Inc ALDX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -1,19% 4,16 01:02:29
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,23 4,075 4,29 4,16 4,21
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00BWAldeyra Therapeutics Highlights Recent Preclinical Data in..
18/4/202413:00BWAldeyra Therapeutics to Host Research & Development Day on..
28/3/202412:00BWAldeyra Therapeutics Announces Clinical Development Plan for..
07/3/202422:54EDGAR2Form S-3 - Registration statement under Securities Act of..
07/3/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:40EDGAR2Form S-8 POS - Securities to be offered to employees in..
07/3/202422:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202413:00BWAldeyra Therapeutics to Participate in the Oppenheimer 34th..
29/1/202423:25EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202413:00EDGAR2Form 8-K - Current report
04/1/202413:00BWAldeyra Therapeutics Provides Clinical and Regulatory Update..
21/12/202322:06EDGAR2Form 8-K - Current report
19/12/202313:05EDGAR2Form 8-K - Current report
19/12/202313:00BWAldeyra Therapeutics Announces Statistically and Clinically..
18/12/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
28/11/202313:16EDGAR2Form 8-K - Current report
27/11/202322:07BWAldeyra Therapeutics Receives Complete Response Letter from..
03/11/202321:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/11/202321:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202312:09EDGAR2Form 8-K - Current report
01/11/202312:05BWAldeyra Therapeutics Enters into Exclusive Option Agreement..
16/10/202314:00EDGAR2Form 8-K - Current report
27/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/9/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/8/202311:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
09/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04/8/202311:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
03/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/7/202313:00BWAldeyra Therapeutics to Participate in SVB Securities..
05/7/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:07EDGAR2Form 8-K - Current report
29/6/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202313:01EDGAR2Form 8-K - Current report
29/6/202313:00BWAldeyra Therapeutics Announces Improvement from Baseline in..
28/6/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
27/6/202313:00BWAldeyra Therapeutics Announces Statistically Significant..
26/6/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
23/6/202313:00BWAldeyra Therapeutics to Join the Russell 2000® and Russell..
21/6/202315:34BWAldeyra Therapeutics Provides Regulatory Update on ADX-2191
15/6/202313:00BWAldeyra Therapeutics Announces Achievement of Statistical..
14/6/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..

Dernières Valeurs Consultées

NASDAQ
ALDX
Aldeyra Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés